Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal vs Intramuscular Ketamine and Midazolam for Pediatric Sedation
NCT03860831Phase 1Unknown
- Sponsor
- Ain Shams University
- Start
- Mar 2019
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of ketamine and midazolam in Procedural sedation (PS) (2 arms), sponsored by Ain Shams University. Primary endpoint: Change in sedation level evaluated by Pediatric Sedation State Scale (PSSS). Status: unknown.
02
Drugs
ketaminemidazolam
03
Conditions
Procedural sedation (PS)
Beyond the preview
Go deeper on NCT03860831.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03860831.